An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

RecruitingOBSERVATIONAL
Enrollment

50,000

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Interventions
DRUG

Finerenone (BAY 94-8862)

10 mg or 20 mg daily

Trial Locations (4)

13353

RECRUITING

Bayer, Berlin

07981

COMPLETED

Many Locations, Multiple Locations

Unknown

COMPLETED

Many Locations, Multiple Locations

NOT_YET_RECRUITING

Many Locations, Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY